Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease

Current Biology

Volumn 13, Issue 8, 2003, Pages 669-673

  Ferri, Anna ^a   Sanes, Joshua R ^b   Coleman, Michael P ^c   Cunningham, Jeanette M ^b   Kato, Ann C ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; WALLERIA;

EID: 0344950387     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(03)00206-9     Document Type: Article

References (20)

1. Cleveland, D., and Rothstein, J. (2001). From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat. Rev. Neurosci. 2, 806-819.
2. Schmalbruch, H., Jensen, H.J., Bjaerg, M., Kamieniecka, Z., and Kurland, L. (1991). A new mouse model with progressive motor neuronopathy. J. Neuropathol. Exp. Neurol. 50, 192-204.
3. Martin, N., Jaubert, J., Gounon, P., Salido, E., Haase, G., Szatanik, M., and Guenet, J.L. (2002). A missense mutation in Tbce causes progressive motor neuronopathy in mice. Nat. Genet. 32, 443-447.
4. Bommel, H., Xie, G., Rossoll, W., Wiese, S., Jablonka, S., Boehm, T., and Sendtner, M. (2002). Missense mutation in the tubulin-specific chaperone E (Tbce) gene in the mouse mutant progressive motor neuronopathy, a model of human motoneuron disease. J. Cell Biol. 159, 563-569.
5. Sagot, Y., Dubois-Dauphin, M., Tan, S.A., de Bilbao, F., Aebischer, P., Martinou, J.C., and Kato, A.C. (1995). Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci. 15, 7727-7733.
6. Sagot, Y., Tan, S.A., Hammang, J.P., Aebischer, P., and Kato, A.C. (1996). GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J. Neurosci. 16, 2335-2341.
7. s mutant mouse. J. Physiol. 534, 627-639.
8. Coleman, M.P., and Perry, V.H. (2002). Axon pathology in neurological disease: a neglected therapeutic target. Trends Neurosci. 25, 532-537.
9. Mack, T.G., Reiner, M., Beirowski, B., Mi, W., Emanuelli, M., Wagner, D., Thomson, D., Gillingwater, T., Court, F., Conforti, L., et al. (2001). Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 4, 1199-1206.
10. Sagot, Y., Tan, S.A., Baetge, E., Schmalbruch, H., Kato, A.C., and Aebischer, P. (1995b). Polymer encapsulated cell lines genetically engineered to release ciliary neurotrophic factor can slow down progressive motor neuronopathy in the mouse. Eur. J. Neurosci. 7, 1313-1322.
11. Sagot, Y., Rosse, T., Vejsada, R., Perrelet, D., and Kato, A.C. (1998). Differential effects of neurotrophic factors on motoneuron retrograde labeling in a murine model of motoneuron disease. J. Neurosci. 18, 1132-1141.
12. Kennel, P.F., Fonteneau, P., Martin, E., Schmidt, J.M., Azzouz, M., Borg, J., Guenet, J.L., Schmalbrach, H., Warter, J.M., and Poindron, P. (1996). Electrophysiological and motor performance studies in the pmn mouse model of neurodegenerative disease. Neurobiol. Dis. 3, 137-147.
13. s mutant and Ube4b/Nmnat transgenic mice. J. Physiol. 543, 739-755.
14. Julien, J.P. (2001). Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 104, 581-591.
15. LaMonte, B.H., Wallace, K.E., Holloway, B.A., Shelly, S.S., Ascano, J., Tokito, M., Ribchester, R.R., Van Winkle, T., Howland, D.S., and Holzbaur, E.L. (2002). Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34, 715-727.
16. Deckwerth, T.L., and Johnson, E.M., Jr. (1994). Neurites can remain viable after destruction of the neuronal soma by programmed cell death (apoptosis). Dev. Biol. 165, 63-72.
17. Raft, M.C., Whitmore, A.V., and Finn, J.T. (2002). Axonal self-destruction and neurodegeneration. Science 296, 868-871.
18. Sendtner, M., Schmalbruch, H., Stockli, K.A., Carroll, P., Kreutzberg, G.W., and Thoenen, H. (1992). Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature 358, 502-504.
19. Haase, G., Kennel, P., Pettmann, B., Vigne, E., Akli, S., Revah, F., Schmalbruch, H., and Kahn, A. (1997). Gene therapy of murine motor neuron disease using adenoviral vectors for neurotrophic factors. Nat. Med. 3, 429-439.
20. Patton, B.L., Cunningham, J.M., Thyboll, J. Kortesmaa, J., Westerblad, H., Edstrom, L., Tryggvason, K., and Sanes, J.R. (2001). Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. Nat. Neurosci. 4, 597-604.